Influenza vaccination options to prevent hospitalization

Moshe Ipp Frcp1, Nancy L Young, Teresa To

  • 1Division of Paediatric Medicine, Department of Paediatrics, The Hospital for Sick Children, University of Toronto;

Paediatrics & Child Health
|December 19, 2009
PubMed

Insights

Universal childhood influenza vaccination could prevent over half of hospitalizations, more than double targeted approaches. Targeted vaccination remains a viable option until universal strategy challenges are resolved.

Area of Science:

  • Pediatric Infectious Diseases
  • Vaccinology
  • Public Health

Background:

  • Influenza causes significant childhood illness, yet vaccination remains debated.
  • Understanding the impact of different vaccination strategies is crucial for public health policy.

Purpose of the Study:

  • To quantify the effectiveness of three distinct influenza vaccination strategies in preventing pediatric hospitalizations.
  • To compare universal versus targeted vaccination approaches for children.

Main Methods:

  • Retrospective chart review of children hospitalized with influenza over three seasons.
  • Analysis included 208 children, categorized as high-risk or previously healthy.
  • Evaluation of universal, selective (risk-based), and infant-only vaccination strategies.

Main Results:

  • A universal vaccination strategy (all children >6 months) could have prevented 118 admissions.
  • Targeted vaccination of high-risk children (>6 months) or infants (2-6 months) could have prevented 58 and 55 admissions, respectively.
  • Universal vaccination prevented more than twice the number of admissions compared to targeted strategies.

Conclusions:

  • Universal influenza vaccination offers substantial benefits, potentially preventing over 50% of pediatric hospitalizations.
  • Targeted vaccination is an acceptable alternative, particularly while implementation challenges of universal vaccination are addressed.
  • The findings support a strong public health recommendation for universal childhood influenza immunization.
Abstract

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Vaccinations01:51

Vaccinations

Overview
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...